mean fasting blood glucose and hba1c
Item
failing maximal oral treatment, defined as mean fasting blood glucose over 8 mmol/l and hba1c over 7.5% for three months or more
boolean
C0428568 (UMLS CUI [1])
C0202054 (UMLS CUI [2])
BMI
Item
bmi 25 - 35 kg/m2
boolean
C1305855 (UMLS CUI [1])
fasting plasma c-peptide level
Item
fasting plasma c-peptide level over 0.3 nmol/l
boolean
C2208720 (UMLS CUI [1])
stable metformin and sulfonylurea dose
Item
stable metformin and sulfonylurea dose for at least three months
boolean
C0025598 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0038766 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Stable weight
Item
stable weight for at least three months (change maximal 2 kg)
boolean
C0005910 (UMLS CUI [1])
Fasting glucose
Item
fasting glucose over 25 mmol/l
boolean
C0202045 (UMLS CUI [1])
Use of alpha-glucosidase inhibitors or thiazolidinediones
Item
use of alpha-glucosidase inhibitors or thiazolidinediones in the two months preceding the study
boolean
C1299007 (UMLS CUI [1])
C1257987 (UMLS CUI [2])
Renal or liver failure
Item
renal or liver failure defined as serum creatinine over 150 micromol/l, liver enzymes over 1.5 upper normal limit
boolean
C0201976 (UMLS CUI [1])
C0428321 (UMLS CUI [2])
Heart failure
Item
heart failure
boolean
C0018801 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Alcohol consumption
Item
alcohol more than two units per day
boolean
C0038586 (UMLS CUI [1])
inflammatory or infectious diseases
Item
inflammatory or infectious diseases
boolean
C1290884 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
unstable chronic disease
Item
unstable chronic disease
boolean
C0009488 (UMLS CUI [1])
discontinuation of smoking
Item
discontinuation of smoking within three months of randomisation date
boolean
C0425310 (UMLS CUI [1])
allergy for or intolerance of glimepiride or novorapid
Item
allergy for or intolerance of glimepiride or novorapid.
boolean
C0020517 (UMLS CUI [1,1])
C0061323 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0939412 (UMLS CUI [2,2])